Publication year: 2008
: 978-1-4020-8696-0
The last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies or other targeting molecules labelled with nuclides. The expanding array of new targeting molecules (recombinant antibodies or peptides) may increase the therapeutic efficacy. The title of this book "Targeted Radionuclide Tumor Therapy – Biological aspects" was selected to reinforce the concept that a major focus was devoted to understanding the biological effects of targeting and radiation. Furthermore, our rapidly expanding knowledge of low dose-rate effects, different types of cell death, autosensitization and the increasingly likely existence of cancer stem cells suggests to us that even more efficient approaches in targeting might be possible in the future.
: Medicine, Cancer Treatment, Cure vs Palliation, Monoclonal Antibodies, Radioimmunotherapy, Targeted Tumor Therapy, Tumor, surgery, Diagnostic Radiology, Cancer Research, Oncology, Nuclear Medicine